Not Yet RecruitingPhase 1ACTRN12605000727640
Angiogenesis II-Safety and feasibility of autologous mesenchymal precursor cells (MPCs) in chronic myocardial ischaemia.
Sponsor
Mesoblast
Enrollment
10 participants
Start Date
Nov 2, 2006
Study Type
Interventional
Conditions
Eligibility
Sex: Both males and females
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying Angiogenesis II-Safety and feasibility of autologous mesenchymal precursor cells (MPCs) in chronic myocardial ischaemia. It is looking for adults who may be eligible to participate. Participation may involve regular medical assessments and follow-up visits.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Left ventericular electromechanical mapping and adminsitration of MPCs
Left ventericular electromechanical mapping and adminsitration of MPCs
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12605000727640